Compassionate use: Putting drug regulations to the test
When should pharmaceutical companies grant compassionate use of experimental treatments? How readily available should the drugs be? A PBS news segment considers these issues.
When should pharmaceutical companies give gravely ill patients access to experimental treatments? The above news segment offers an good summary of the issues involved in this vexed ethical dilemma.
Compassionate Use Putting drug regulations to the test
Xavier Symons
https://www.bioedge.org/images/2008images/TH_savejosh.jpg
Creative commons
clinical trials
compassionate use
- Can machines be moral? - March 7, 2021
- Can we synthesise Christianity moral theology with secular bioethics? - November 28, 2020
- Euthanasia polling data may fail to capture people’s considered views - August 15, 2020
More Stories
Could newborns solve the kidney shortage crisis?
Kidneys from newborn babies could be a “game-changing” solution to organ shortage crisis, according to an American study. According to...
Chinese sperm bank pushes the boundaries in its marketing
With a birth rate of 1.09 and a declining population, there is a sense of urgency in China about reversing...
Chinese scientists grow humanized kidneys in pigs
Chinese scientists have successfully created chimeric embryos containing a combination of human and pig cells. When transferred into surrogate pig...
People born from donor gametes in UK will be able to doorknock their dad
As of October 1, 18-year-olds in the United Kingdom conceived with donor gametes will be able to find out who...
British teen dies after doctors refuse her request for experimental treatment
ST, the 19-year-old woman at the centre of a dispute about mental competence and healthcare in Britain, has died of...
Dodging a bullet: how a report recommending ‘chestfeeding’ and inclusive pronouns almost became the norm in British maternity wards
A transgender maternity report commissioned by public health authorities in the UK last year made headlines by recommending the use...